Ivã Guidini Lopes, Nathali Machado de Lima, Teresa Ribeiro, Daniel Murta, Jean Wan Hong Yong, Cecilia Lalander
Olive pomace (OP) is a sludge arising from the production of olive oil, generated in increasing amounts in Portugal. The management of this toxic waste stream is complex and the number of processing plants is limited. In this study, OP was incorporated as a feed component for rearing black soldier fly larvae (BSFL) under industrial conditions. Larvae were reared inside a climate-controlled room with regulated temperature and humidity. The rearing cycle lasted 13 days, after which larvae were harvested. In addition to assessing bioconversion efficiency and larval proximate composition, the resulting frass was examined for its fertilizer potential. Frass was analyzed for plant nutrient content and microbial profile in three forms: fresh, heat-treated (70°C for 1 h), and pelletized. The inclusion of OP in the diets reduced waste-to-biomass conversion efficiency (21.5%DM to approximately 13.3%DM) but did not affect the proximate composition of the larval biomass, which consistently contained around 43%DM crude protein and 20%DM crude fat. Neither the presence of OP nor the applied post-treatments altered the nutrient composition of frass, which contained on average 3.5% total N, 2.6% P2O5, and 5.9% K2O. However, at the highest inclusion level (84%), the abundance of bacterial and fungal groups was significantly reduced. The predominant phyla in the frass were Actinobacteria, Bacteroidota, Firmicutes, Proteobacteria, Ascomycota and Basidiomycota, and the dynamics of microbial communities were influenced by specific micronutrients. The presence of OP led to a significant reduction of potentially pathogenic bacteria and fungi in the frass, indicating a sanitizing effect attributable to this material.
{"title":"Olive Pomace Inclusion Alters the Microbial Community of Black Soldier Fly Larvae Frass While Maintaining Fertilizer Quality","authors":"Ivã Guidini Lopes, Nathali Machado de Lima, Teresa Ribeiro, Daniel Murta, Jean Wan Hong Yong, Cecilia Lalander","doi":"10.1002/mbo3.70180","DOIUrl":"10.1002/mbo3.70180","url":null,"abstract":"<p>Olive pomace (OP) is a sludge arising from the production of olive oil, generated in increasing amounts in Portugal. The management of this toxic waste stream is complex and the number of processing plants is limited. In this study, OP was incorporated as a feed component for rearing black soldier fly larvae (BSFL) under industrial conditions. Larvae were reared inside a climate-controlled room with regulated temperature and humidity. The rearing cycle lasted 13 days, after which larvae were harvested. In addition to assessing bioconversion efficiency and larval proximate composition, the resulting frass was examined for its fertilizer potential. Frass was analyzed for plant nutrient content and microbial profile in three forms: fresh, heat-treated (70°C for 1 h), and pelletized. The inclusion of OP in the diets reduced waste-to-biomass conversion efficiency (21.5%<sub>DM</sub> to approximately 13.3%<sub>DM</sub>) but did not affect the proximate composition of the larval biomass, which consistently contained around 43%<sub>DM</sub> crude protein and 20%<sub>DM</sub> crude fat. Neither the presence of OP nor the applied post-treatments altered the nutrient composition of frass, which contained on average 3.5% total N, 2.6% P<sub>2</sub>O<sub>5</sub>, and 5.9% K<sub>2</sub>O. However, at the highest inclusion level (84%), the abundance of bacterial and fungal groups was significantly reduced. The predominant phyla in the frass were Actinobacteria, Bacteroidota, Firmicutes, Proteobacteria, Ascomycota and Basidiomycota, and the dynamics of microbial communities were influenced by specific micronutrients. The presence of OP led to a significant reduction of potentially pathogenic bacteria and fungi in the frass, indicating a sanitizing effect attributable to this material.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12665153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145635766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hongfang Chen, Xiuying Zhang, Shijun Li, Yi Fang, Yi Han, Xiaoqian Jing
Emerging evidence suggests that OBSCN, a giant cytoskeletal protein gene, plays multifaceted roles in cancer progression, yet its impact on gastric cancer (GC) remains poorly understood. Through integrative analysis of multi-omics datasets, we observe a close relationship between OBSCN expression and outcome of immunotherapy. Besides, elevated expression of OBSCN strongly associated with adverse disease free survival (DFS). Tumor-resident microbes, such as Fusobacterium, can impact the expression of microRNAs (miRNAs) targeting OBSCN. In terms of genomic alterations, mutational status of OBSCN is substantially associated with the alpha- and beta-diversity of intratumoral microbiome and patients with mutated OBSCN exhibit elevated higher tumor mutational burden (TMB) and better response to immunotherapy. Furthermore, machine learning models based on the OBSCN mutation-related gene signatures (OMRGS) achieve outstanding performance in prediction of response to immune checkpoint inhibitors. In summary, our findings position OBSCN as a novel molecular nexus linking genomic alterations, intratumoral microbiome dysbiosis, and immune infiltration in GC, providing a rationale for future biomarker-driven therapeutic strategies.
{"title":"Multi-Omics Analysis Reveals OBSCN as a Key Modulator of Tumor Microenvironment, Microbial Signatures and Clinical Outcomes in Gastric Cancer","authors":"Hongfang Chen, Xiuying Zhang, Shijun Li, Yi Fang, Yi Han, Xiaoqian Jing","doi":"10.1002/mbo3.70186","DOIUrl":"10.1002/mbo3.70186","url":null,"abstract":"<p>Emerging evidence suggests that <i>OBSCN</i>, a giant cytoskeletal protein gene, plays multifaceted roles in cancer progression, yet its impact on gastric cancer (GC) remains poorly understood. Through integrative analysis of multi-omics datasets, we observe a close relationship between <i>OBSCN</i> expression and outcome of immunotherapy. Besides, elevated expression of <i>OBSCN</i> strongly associated with adverse disease free survival (DFS). Tumor-resident microbes, such as <i>Fusobacterium</i>, can impact the expression of microRNAs (miRNAs) targeting <i>OBSCN</i>. In terms of genomic alterations, mutational status of <i>OBSCN</i> is substantially associated with the alpha- and beta-diversity of intratumoral microbiome and patients with mutated <i>OBSCN</i> exhibit elevated higher tumor mutational burden (TMB) and better response to immunotherapy. Furthermore, machine learning models based on the <i>OBSCN</i> mutation-related gene signatures (OMRGS) achieve outstanding performance in prediction of response to immune checkpoint inhibitors. In summary, our findings position <i>OBSCN</i> as a novel molecular nexus linking genomic alterations, intratumoral microbiome dysbiosis, and immune infiltration in GC, providing a rationale for future biomarker-driven therapeutic strategies.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12665479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145648922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The rise in azole resistance among Nakaseomyces glabratus and Pichia kudriavzevii in recurrent vulvovaginal candidiasis presents a growing public health challenge. This study investigated the expression of antifungal resistance-related genes (ERG11, CDR1, CDR2, and MDR1) in clinical resistant (CR) and clinical and laboratory resistant (CLR) strains of these yeasts. Cervicovaginal samples from patients with recurrent infections were collected, microscopically examined, and cultured. Yeast species were identified phenotypically and genotypically, followed by drug sensitivity testing. Total RNA was extracted, reverse transcribed to complementary DNA, and real-time polymerase chain reaction was used to quantify target gene expression, comparing results to drug-sensitive controls. Non-Candida albicans species constituted 29% (45 cases) of the isolates, with N. glabratus (68%) and P. kudriavzevii (17%) being the dominant species. Other species included Candida parapsilosis, Meyerozyma guilliermondii, Candida orthopsilosis, Saccharomyces cerevisiae, and Rhodotorula mucilaginosa. Coinfections with P. kudriavzevii/C. albicans and N. glabratus/C. albicans were also observed. Ketoconazole, itraconazole, and 5-flucytosine demonstrated the best antifungal activity against most species. However, some N. glabratus isolates were resistant to miconazole, clotrimazole, and amphotericin B, while all P. kudriavzevii isolates resisted clotrimazole. Overexpression of the CDR1 gene was noted in N. glabratus (CR, 21.53 ± 1.26; CLR, 84.96 ± 0.67), and the ERG11 and CDR1 genes in P. kudriavzevii (ERG11 for CR, 28.56 ± 2.16; CDR1 for CLR, 35.89 ± 0.35). These results indicate that even in cases where an isolate is classified as susceptible by drug susceptibility testing, elevated gene expression may persist, and treatment should not be discontinued.
{"title":"Non-albicans Candida in Vulvovaginal Candidiasis: Antifungal Resistance and Expression of ERG11, CDR1, CDR2, and MDR1 Genes","authors":"Fatemeh Zahra Ranjbar Golafshani, Firoozeh Kermani, Soheila Abbaszadeh Godarzi, Saeid Mahdavi Omran","doi":"10.1002/mbo3.70123","DOIUrl":"10.1002/mbo3.70123","url":null,"abstract":"<p>The rise in azole resistance among <i>Nakaseomyces glabratus</i> and <i>Pichia kudriavzevii</i> in recurrent vulvovaginal candidiasis presents a growing public health challenge. This study investigated the expression of antifungal resistance-related genes (<i>ERG11</i>, <i>CDR1</i>, <i>CDR2</i>, and <i>MDR1</i>) in clinical resistant (CR) and clinical and laboratory resistant (CLR) strains of these yeasts. Cervicovaginal samples from patients with recurrent infections were collected, microscopically examined, and cultured. Yeast species were identified phenotypically and genotypically, followed by drug sensitivity testing. Total RNA was extracted, reverse transcribed to complementary DNA, and real-time polymerase chain reaction was used to quantify target gene expression, comparing results to drug-sensitive controls. Non-<i>Candida albicans</i> species constituted 29% (45 cases) of the isolates, with <i>N. glabratus</i> (68%) and <i>P. kudriavzevii</i> (17%) being the dominant species. Other species included <i>Candida parapsilosis, Meyerozyma guilliermondii</i>, <i>Candida orthopsilosis</i>, <i>Saccharomyces cerevisiae</i>, and <i>Rhodotorula mucilaginosa</i>. Coinfections with <i>P. kudriavzevii/C. albicans</i> and <i>N. glabratus/C. albicans</i> were also observed. Ketoconazole, itraconazole, and 5-flucytosine demonstrated the best antifungal activity against most species. However, some <i>N. glabratus</i> isolates were resistant to miconazole, clotrimazole, and amphotericin B, while all <i>P. kudriavzevii</i> isolates resisted clotrimazole. Overexpression of the <i>CDR1</i> gene was noted in <i>N. glabratus</i> (CR, 21.53 ± 1.26; CLR, 84.96 ± 0.67), and the <i>ERG11</i> and <i>CDR1</i> genes in <i>P. kudriavzevii</i> (<i>ERG11</i> for CR, 28.56 ± 2.16; <i>CDR1</i> for CLR, 35.89 ± 0.35). These results indicate that even in cases where an isolate is classified as susceptible by drug susceptibility testing, elevated gene expression may persist, and treatment should not be discontinued.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12665148/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145635744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The emergence and dissemination of aquatic pathogens pose significant risks to farmed species. Francisella halioticida, initially reported in abalones and Yesso scallops, was recently isolated from mussels in France, with some isolates showing high virulence. This study aimed to characterize and compare several F. halioticida isolates from mussels using phenotypic and genotypic approaches. Phenotypic analysis was performed using growth curves, biochemical profiles (API strips), and morphology assessed by electron microscopy. Genetic analysis has been performed through whole-genome comparison using classification methods and virulence markers seeking. Phenotypic analyses highlighted similarities among FR22 isolates and notable differences with FR21 and AG1. Notably, AG1 displayed distinct features. Antibiotic resistance profiling revealed the species' capacity to withstand multiple antimicrobial agents with various modes of action. Complete, circular genomes were assembled and compared using targeted and untargeted approaches. These analyses confirmed the affiliation of FR22 isolates with the F. halioticida species, while FR21 and AG1 taxonomy need to be further investigated. Virulence factor screening revealed the presence of secretion system components (types I, IV, and VI) in all isolates. A novel variant of the Francisella Pathogenicity Island (FPI) was described, shared by all virulent isolates. However, this FPI was absent in the low virulence isolate FR22b. In conclusion, this study discriminates against F. halioticida isolates and proposes new hypotheses on their virulence, contributing to improved detection tools and expanding our understanding of this emerging aquatic pathogen.
{"title":"Phenotypical and Genomic Characterization of the Mollusk Pathogen Francisella halioticida","authors":"Hélène Bouras, Yann Quesnelle, Suzanne Trancart, Didier Goux, Jean-Louis Blin, Manuel Savary, Maryline Houssin, Céline Zatylny-Gaudin","doi":"10.1002/mbo3.70172","DOIUrl":"https://doi.org/10.1002/mbo3.70172","url":null,"abstract":"<p>The emergence and dissemination of aquatic pathogens pose significant risks to farmed species. <i>Francisella halioticida</i>, initially reported in abalones and Yesso scallops, was recently isolated from mussels in France, with some isolates showing high virulence. This study aimed to characterize and compare several <i>F. halioticida</i> isolates from mussels using phenotypic and genotypic approaches. Phenotypic analysis was performed using growth curves, biochemical profiles (API strips), and morphology assessed by electron microscopy. Genetic analysis has been performed through whole-genome comparison using classification methods and virulence markers seeking. Phenotypic analyses highlighted similarities among FR22 isolates and notable differences with FR21 and AG1. Notably, AG1 displayed distinct features. Antibiotic resistance profiling revealed the species' capacity to withstand multiple antimicrobial agents with various modes of action. Complete, circular genomes were assembled and compared using targeted and untargeted approaches. These analyses confirmed the affiliation of FR22 isolates with the <i>F. halioticida</i> species, while FR21 and AG1 taxonomy need to be further investigated. Virulence factor screening revealed the presence of secretion system components (types I, IV, and VI) in all isolates. A novel variant of the <i>Francisella</i> Pathogenicity Island (FPI) was described, shared by all virulent isolates. However, this FPI was absent in the low virulence isolate FR22b. In conclusion, this study discriminates against <i>F. halioticida</i> isolates and proposes new hypotheses on their virulence, contributing to improved detection tools and expanding our understanding of this emerging aquatic pathogen.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mbo3.70172","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145626625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The rise of antibiotic-resistant bacteria has intensified the search for alternative antibacterial strategies. Bacteriophage (phage) therapy is gaining attention as a promising approach, utilizing phage-derived proteins such as holins and endolysins to combat bacterial infections. In this study, the endolysin (UE-lysin) and holin (UE-holin) genes from Escherichia phage UE-M6 were characterized, and their antimicrobial activity was evaluated. In silico analysis revealed that UE-lysin has a modular architecture, with the N-terminal enzymatic activity domain that contains an N-acetylmuramidase of the glycoside hydrolase family GH108, and the C-terminal cell wall-binding domain that contains the peptidoglycan binding family PG_binding_3 domain. UE-holin was predicted to belong to class II holins, featuring two transmembrane helices. Furthermore, the genes encoding the UE-lysin and UE-holin were cloned and their expression optimized in Escherichia coli BL21 (DE3). The purified recombinant UE-lysin (27 kDa) and UE-holin (15 kDa) exhibited antibacterial activity against the E. coli host strain PSU-5266 (UE-17). The addition of the outer membrane permeabilizer ethylenediaminetetraacetic acid further enhanced their activity. Notably, the combined application of UE-holin and UE-lysin demonstrated greater antibacterial efficacy than either enzyme alone, highlighting a synergistic effect. Furthermore, UE-lysin and UE-holin exhibited high lytic activity against E. coli, Bacillus, and Staphylococcus aureus strains, underscoring their potential as candidates for treating both Gram-negative and Gram-positive bacterial infections.
{"title":"Molecular Cloning and Functional Analysis of Holin and Endolysin From Escherichia Phage UE-M6 as Potential Antibacterial Agents","authors":"Hira Niaz, Mikael Skurnik, Fazal Adnan","doi":"10.1002/mbo3.70150","DOIUrl":"https://doi.org/10.1002/mbo3.70150","url":null,"abstract":"<p>The rise of antibiotic-resistant bacteria has intensified the search for alternative antibacterial strategies. Bacteriophage (phage) therapy is gaining attention as a promising approach, utilizing phage-derived proteins such as holins and endolysins to combat bacterial infections. In this study, the endolysin (UE-lysin) and holin (UE-holin) genes from <i>Escherichia</i> phage UE-M6 were characterized, and their antimicrobial activity was evaluated. In silico analysis revealed that UE-lysin has a modular architecture, with the <i>N</i>-terminal enzymatic activity domain that contains an <i>N</i>-acetylmuramidase of the glycoside hydrolase family GH108, and the <i>C</i>-terminal cell wall-binding domain that contains the peptidoglycan binding family PG_binding_3 domain. UE-holin was predicted to belong to class II holins, featuring two transmembrane helices. Furthermore, the genes encoding the UE-lysin and UE-holin were cloned and their expression optimized in <i>Escherichia coli</i> BL21 (DE3). The purified recombinant UE-lysin (27 kDa) and UE-holin (15 kDa) exhibited antibacterial activity against the <i>E. coli</i> host strain PSU-5266 (UE-17). The addition of the outer membrane permeabilizer ethylenediaminetetraacetic acid further enhanced their activity. Notably, the combined application of UE-holin and UE-lysin demonstrated greater antibacterial efficacy than either enzyme alone, highlighting a synergistic effect. Furthermore, UE-lysin and UE-holin exhibited high lytic activity against <i>E. coli</i>, <i>Bacillus</i>, and <i>Staphylococcus aureus</i> strains, underscoring their potential as candidates for treating both Gram-negative and Gram-positive bacterial infections.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mbo3.70150","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145619313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Henni Tuomala, Julia Holtel, Melina Markkanen, Sheetal Patpatia, Katariina Kaansalo, Clara Rolland, Oliver W. Bayfield, Kira Ranta, Mikael Skurnik, Johannes Wittmann, Saija Kiljunen
Therapeutically utilized phages should optimally be produced in defined bacterial strains that are free of prophages and virulence factors. However, phage–host interactions in these production strains may be very different from clinical strains. Here, we characterized a lytic Staphylococcus aureus–specific phage vB_SauP_EBHT (EBHT), which had a dramatic change in its host specificity when produced in alternative host 19A2 compared with the original isolation host DSM 104437, even though there were no changes in the phage genome, proteome, structure, or adsorption efficiency. The reason for the altered host range was revealed to be based on different methylation patterns of the EBHT genome by host restriction–modification (R-M) systems in the two hosts. Even though the alternative host 19A2 produced a higher burst size, the host range of the produced phages was narrower. Together, these results illustrate that the most efficient production host may not necessarily be the most optimal one and that bacterial R-M systems should be considered when selecting the optimal phage-production host.
{"title":"The Host R-M Systems Change the Host Range of Staphylococcus Phage EBHT","authors":"Henni Tuomala, Julia Holtel, Melina Markkanen, Sheetal Patpatia, Katariina Kaansalo, Clara Rolland, Oliver W. Bayfield, Kira Ranta, Mikael Skurnik, Johannes Wittmann, Saija Kiljunen","doi":"10.1002/mbo3.70165","DOIUrl":"https://doi.org/10.1002/mbo3.70165","url":null,"abstract":"<p>Therapeutically utilized phages should optimally be produced in defined bacterial strains that are free of prophages and virulence factors. However, phage–host interactions in these production strains may be very different from clinical strains. Here, we characterized a lytic <i>Staphylococcus aureus</i>–specific phage vB_SauP_EBHT (EBHT), which had a dramatic change in its host specificity when produced in alternative host 19A2 compared with the original isolation host DSM 104437, even though there were no changes in the phage genome, proteome, structure, or adsorption efficiency. The reason for the altered host range was revealed to be based on different methylation patterns of the EBHT genome by host restriction–modification (R-M) systems in the two hosts. Even though the alternative host 19A2 produced a higher burst size, the host range of the produced phages was narrower. Together, these results illustrate that the most efficient production host may not necessarily be the most optimal one and that bacterial R-M systems should be considered when selecting the optimal phage-production host.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mbo3.70165","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145619189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lori I. Robins, Philip Gafken, Chenwei Lin, Lisa Jones, Sarah E. Hooper
Pseudomonas aeruginosa is found in 48%–52% of chronic wound biofilms, where its resistance to antimicrobials and host immunity presents a major clinical challenge. Although hypochlorous acid (HOCl) is known to be an effective antimicrobial, its mechanism of action remains unclear because standard experimental conditions often produce a mixture of HOCl and hypochlorite (OCl⁻), making it difficult to isolate the effects of HOCl. Here, we use proteomic profiling to investigate the effects of a pure, stable HOCl gel on P. aeruginosa biofilms in a physiologically relevant chronic wound model. We applied HOCl gel (5.7 mM, pH 6) to mature P. aeruginosa biofilms established in a wound-mimicking flow model. Proteins were analyzed using tandem mass tag (TMT)-based quantitative proteomics, identifying 1,878 proteins. HOCl treatment significantly reduced biofilm viability and altered the abundance of 330 proteins. We observed substantial depletion of proteins involved in biosynthesis, virulence, antibiotic resistance, and biofilm formation, alongside enrichment of stress response proteins. These findings indicate a shift toward survival phenotypes and weakened pathogenicity. Our data reveal that HOCl disrupts multiple pathways essential for P. aeruginosa survival and virulence. Crucially, our experimental design eliminates confounding factors that can lead to unintentional testing of mixed HOCl and OCl⁻ species, allowing us to assess the specific effects of HOCl. These findings call for a re-evaluation of HOCl research methodologies and reiterate the importance of realistic infection models in antimicrobial testing.
铜绿假单胞菌存在于48%-52%的慢性伤口生物膜中,其对抗菌剂和宿主免疫的耐药性是一个重大的临床挑战。虽然我们知道次氯酸(HOCl)是一种有效的抗菌药物,但它的作用机制仍然不清楚,因为标准的实验条件经常会产生HOCl和次氯酸(OCl)的混合物,这使得很难分离HOCl的作用。在这里,我们使用蛋白质组学分析来研究纯的、稳定的HOCl凝胶在生理相关的慢性伤口模型中对铜绿假单胞菌生物膜的影响。我们将HOCl凝胶(5.7 mM, pH 6)应用于在模拟伤口流动模型中建立的成熟铜绿假单胞菌生物膜。采用基于串联质量标签(TMT)的定量蛋白质组学方法对蛋白质进行分析,鉴定出1878个蛋白质。HOCl处理显著降低了生物膜活力,改变了330个蛋白的丰度。我们观察到与生物合成、毒力、抗生素耐药性和生物膜形成相关的蛋白质大量减少,同时应激反应蛋白富集。这些发现表明了向生存表型和致病性减弱的转变。我们的数据显示HOCl破坏了铜绿假单胞菌生存和毒力所必需的多种途径。至关重要的是,我们的实验设计消除了可能导致HOCl和OCl混合测试的混杂因素,使我们能够评估HOCl的具体效果。这些发现呼吁对HOCl研究方法进行重新评估,并重申现实感染模型在抗菌药物检测中的重要性。
{"title":"Dissecting HOCl Action in Chronic Wound Biofilms: Proteomic Insights From a Host-Relevant Model of Pseudomonas aeruginosa","authors":"Lori I. Robins, Philip Gafken, Chenwei Lin, Lisa Jones, Sarah E. Hooper","doi":"10.1002/mbo3.70181","DOIUrl":"https://doi.org/10.1002/mbo3.70181","url":null,"abstract":"<p><i>Pseudomonas aeruginosa</i> is found in 48%–52% of chronic wound biofilms, where its resistance to antimicrobials and host immunity presents a major clinical challenge. Although hypochlorous acid (HOCl) is known to be an effective antimicrobial, its mechanism of action remains unclear because standard experimental conditions often produce a mixture of HOCl and hypochlorite (OCl⁻), making it difficult to isolate the effects of HOCl. Here, we use proteomic profiling to investigate the effects of a pure, stable HOCl gel on <i>P. aeruginosa</i> biofilms in a physiologically relevant chronic wound model. We applied HOCl gel (5.7 mM, pH 6) to mature <i>P. aeruginosa</i> biofilms established in a wound-mimicking flow model. Proteins were analyzed using tandem mass tag (TMT)-based quantitative proteomics, identifying 1,878 proteins. HOCl treatment significantly reduced biofilm viability and altered the abundance of 330 proteins. We observed substantial depletion of proteins involved in biosynthesis, virulence, antibiotic resistance, and biofilm formation, alongside enrichment of stress response proteins. These findings indicate a shift toward survival phenotypes and weakened pathogenicity. Our data reveal that HOCl disrupts multiple pathways essential for <i>P. aeruginosa</i> survival and virulence. Crucially, our experimental design eliminates confounding factors that can lead to unintentional testing of mixed HOCl and OCl⁻ species, allowing us to assess the specific effects of HOCl. These findings call for a re-evaluation of HOCl research methodologies and reiterate the importance of realistic infection models in antimicrobial testing.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mbo3.70181","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145626345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jadelynn Aki, Sara B. Papp, Bayley Polk, Sean Jeffreys, Megan P. Tompkins, Anwar A. Kalalah, Mark Eppinger, Guoquan Zhang, M. N. Guentzel, James P. Chambers, Bernard P. Arulanandam, Jieh-Juen Yu
Acinetobacter baumannii is a multi-drug resistant Gram-negative coccobacillus. It is responsible for high mortality among patients in the intensive care unit. Reported A. baumannii virulence factors include the thioredoxin system which plays a critical role in gene regulation and protein reduction. The Type IV pilus (T4P) is a well-known bacterial virulence factor that is associated with adhesion and molecular exchange. Previously, our laboratory revealed the role of A. baumannii thioredoxin A (TrxA) in pathogenesis by studying a trxA deletion mutant that downregulates T4P gene expression. TrxA, a potent disulfide bond reducer, might affect the assembly of pili by targeting T4P component proteins, including PilA, the major pilin protein of T4P which contains multiple cysteine residues required for disulfide bond formation. Using a transposon library derived from the AB5075 clinical isolate, we phenotypically characterized a pilA mutant strain and compared its pathogenesis to the wild type (WT) strain as well as another trxA mutant. Whole genome sequencing was conducted to confirm the disruption of trxA and pilA genes in the corresponding mutant strains of AB5075. Alteration of bacterial surface appendages in ΔtrxA and ΔpilA was visualized by Scanning electron microscopy. Like ΔtrxA, the T4P mutant ΔpilA had marked reduction of surface pili. Bacterial attachment to excised intestinal surfaces was greatly reduced for ΔtrxA and ΔpilA. Attenuation of ΔtrxA and ΔpilA in pathogenesis was further confirmed using a mouse sepsis model. Collectively, this characterized ΔpilA deficiency in A. baumannii resulted in attenuation of virulence making it a potential therapeutic target.
鲍曼不动杆菌是一种多重耐药革兰氏阴性球菌。它是重症监护病房病人死亡率高的原因。已报道的鲍曼不动杆菌毒力因子包括在基因调控和蛋白还原中起关键作用的硫氧还蛋白系统。IV型菌毛(T4P)是一种众所周知的细菌毒力因子,与粘附和分子交换有关。之前,我们实验室通过研究一个下调T4P基因表达的TrxA缺失突变体,揭示了鲍曼a.p ummannii thioredoxin A (TrxA)在发病机制中的作用。TrxA是一种有效的二硫键还原剂,它可能通过靶向T4P成分蛋白来影响毛毛的组装,包括T4P的主要毛蛋白PilA,它含有形成二硫键所需的多个半胱氨酸残基。利用AB5075临床分离物的转座子文库,我们对pilA突变株进行了表型表征,并将其发病机制与野生型(WT)菌株和另一种trxA突变株进行了比较。通过全基因组测序确认AB5075突变株中trxA和pilA基因的断裂。通过扫描电镜观察ΔtrxA和ΔpilA细菌表面附属物的变化。与ΔtrxA一样,T4P突变体ΔpilA表面毛明显减少。对于ΔtrxA和ΔpilA,细菌附着在切除的肠道表面大大减少。通过小鼠脓毒症模型进一步证实了ΔtrxA和ΔpilA在发病机制中的衰减作用。总的来说,这种特征的ΔpilA鲍曼芽胞杆菌缺乏导致毒力的衰减,使其成为潜在的治疗靶点。
{"title":"Characterization of Pilin A and Thioredoxin A Mutant Strains of Acinetobacter baumannii, From a Transposon Insertion Library, for Pili Production and Virulence-Associated Properties","authors":"Jadelynn Aki, Sara B. Papp, Bayley Polk, Sean Jeffreys, Megan P. Tompkins, Anwar A. Kalalah, Mark Eppinger, Guoquan Zhang, M. N. Guentzel, James P. Chambers, Bernard P. Arulanandam, Jieh-Juen Yu","doi":"10.1002/mbo3.70183","DOIUrl":"https://doi.org/10.1002/mbo3.70183","url":null,"abstract":"<p><i>Acinetobacter baumannii</i> is a multi-drug resistant Gram-negative coccobacillus. It is responsible for high mortality among patients in the intensive care unit. Reported <i>A. baumannii</i> virulence factors include the thioredoxin system which plays a critical role in gene regulation and protein reduction. The Type IV pilus (T4P) is a well-known bacterial virulence factor that is associated with adhesion and molecular exchange. Previously, our laboratory revealed the role of <i>A. baumannii</i> thioredoxin A (TrxA) in pathogenesis by studying a <i>trxA</i> deletion mutant that downregulates T4P gene expression. TrxA, a potent disulfide bond reducer, might affect the assembly of pili by targeting T4P component proteins, including PilA, the major pilin protein of T4P which contains multiple cysteine residues required for disulfide bond formation. Using a transposon library derived from the AB5075 clinical isolate, we phenotypically characterized a <i>pilA</i> mutant strain and compared its pathogenesis to the wild type (WT) strain as well as another <i>trxA</i> mutant. Whole genome sequencing was conducted to confirm the disruption of <i>trxA</i> and <i>pilA</i> genes in the corresponding mutant strains of AB5075. Alteration of bacterial surface appendages in Δ<i>trxA</i> and Δ<i>pilA</i> was visualized by Scanning electron microscopy. Like Δ<i>trxA</i>, the T4P mutant Δ<i>pilA</i> had marked reduction of surface pili. Bacterial attachment to excised intestinal surfaces was greatly reduced for Δ<i>trxA</i> and Δ<i>pilA</i>. Attenuation of Δ<i>trxA</i> and Δ<i>pilA</i> in pathogenesis was further confirmed using a mouse sepsis model. Collectively, this characterized Δ<i>pilA</i> deficiency in <i>A. baumannii</i> resulted in attenuation of virulence making it a potential therapeutic target.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mbo3.70183","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The evolutionary profile of hepatitis B virus (HBV) quasispecies may influence the clinical course of chronic hepatitis B (CHB), but few studies have characterized quasispecies according to hepatitis B e antigen (HBeAg) status. In this study, we analyzed 289 full-length HBV clones from 19 treatment-naïve CHB patients with long-term infection (> 10 years), comprising nine HBeAg-positive and ten HBeAg-negative, using molecular cloning and Sanger sequencing. Compared with HBeAg-positive patients, HBeAg-negative patients displayed higher quasispecies diversity (mean intrapatient sequence divergence 1.09% vs. 0.44%) and more complex phylogenetic structures. They also exhibited a greater number of positively selected sites, with 70.8% located within known T- or B-cell epitope regions, predominantly in the surface (S), polymerase (Pol), and X regions. Classical basal core promoter (BCP) and precore (PreC) mutations were detected in 52.8% of HBeAg-negative clones, often coexisting with wild-type strains. In patients lacking these classical BCP/preC mutations but showing sustained viremia, intrahost recombination was observed. Moreover, overlapping reading frames, particularly +1 frameshifts in Pol/S region, demonstrated asymmetric distribution patterns. In patients harboring deletion mutations, intact quasispecies were also maintained. Collectively, these findings reveal multiple adaptive strategies that sustain HBV replication and immune escape in HBeAg-negative patients, providing mechanistic insights for disease monitoring and therapeutic interventions.
{"title":"Adaptive Evolution and Distinct Mutation Signatures of Full-Length HBV Quasispecies in HBeAg-Negative Chronic Hepatitis B","authors":"Changhui Wu, Fengwei Liu, Xiao Li, Xiaojin Li, Hui Li, Sihang Zhang, Xiaohui Yan, Taicheng Zhou, Jia Wei","doi":"10.1002/mbo3.70175","DOIUrl":"https://doi.org/10.1002/mbo3.70175","url":null,"abstract":"<p>The evolutionary profile of hepatitis B virus (HBV) quasispecies may influence the clinical course of chronic hepatitis B (CHB), but few studies have characterized quasispecies according to hepatitis B e antigen (HBeAg) status. In this study, we analyzed 289 full-length HBV clones from 19 treatment-naïve CHB patients with long-term infection (> 10 years), comprising nine HBeAg-positive and ten HBeAg-negative, using molecular cloning and Sanger sequencing. Compared with HBeAg-positive patients, HBeAg-negative patients displayed higher quasispecies diversity (mean intrapatient sequence divergence 1.09% vs. 0.44%) and more complex phylogenetic structures. They also exhibited a greater number of positively selected sites, with 70.8% located within known <i>T</i>- or <i>B</i>-cell epitope regions, predominantly in the surface (S), polymerase (Pol), and <i>X</i> regions. Classical basal core promoter (BCP) and precore (PreC) mutations were detected in 52.8% of HBeAg-negative clones, often coexisting with wild-type strains. In patients lacking these classical BCP/preC mutations but showing sustained viremia, intrahost recombination was observed. Moreover, overlapping reading frames, particularly +1 frameshifts in Pol/S region, demonstrated asymmetric distribution patterns. In patients harboring deletion mutations, intact quasispecies were also maintained. Collectively, these findings reveal multiple adaptive strategies that sustain HBV replication and immune escape in HBeAg-negative patients, providing mechanistic insights for disease monitoring and therapeutic interventions.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mbo3.70175","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gladys Maria Pangga, Stephen Bamford, Anne Richmond, Nicolae Corcionivoschi, Umer Zeeshan Ijaz, Ozan Gundogdu
The gut microbiome of breeder hens plays a pivotal role in reproductive efficiency, egg quality, and progeny development. Its composition is shaped by host factors such as age and genetics, as well as environmental influences, including diet and management practices. Importantly, the breeder gut microbiome is not only dynamic but also responsive to targeted interventions that can enhance intestinal health, metabolic function, and laying performance. Vertical transmission of maternal microbes through the cloaca and egg components provides offspring with a foundational microbial community, with the yolk sac serving as a critical reservoir for early colonisers that influence gut maturation, immunity, and growth. Emerging evidence further demonstrates that maternal nutritional strategies can programme the gut microbiota of progeny and intestinal development, highlighting the breeder microbiome as both a determinant and mediator of transgenerational performance. These insights underscore the potential of microbiome-focused approaches to improve reproductive success and sustainability in poultry production.
{"title":"The Transgenerational Link: Breeder Gut Microbiota and Broiler Progeny Development","authors":"Gladys Maria Pangga, Stephen Bamford, Anne Richmond, Nicolae Corcionivoschi, Umer Zeeshan Ijaz, Ozan Gundogdu","doi":"10.1002/mbo3.70174","DOIUrl":"https://doi.org/10.1002/mbo3.70174","url":null,"abstract":"<p>The gut microbiome of breeder hens plays a pivotal role in reproductive efficiency, egg quality, and progeny development. Its composition is shaped by host factors such as age and genetics, as well as environmental influences, including diet and management practices. Importantly, the breeder gut microbiome is not only dynamic but also responsive to targeted interventions that can enhance intestinal health, metabolic function, and laying performance. Vertical transmission of maternal microbes through the cloaca and egg components provides offspring with a foundational microbial community, with the yolk sac serving as a critical reservoir for early colonisers that influence gut maturation, immunity, and growth. Emerging evidence further demonstrates that maternal nutritional strategies can programme the gut microbiota of progeny and intestinal development, highlighting the breeder microbiome as both a determinant and mediator of transgenerational performance. These insights underscore the potential of microbiome-focused approaches to improve reproductive success and sustainability in poultry production.</p>","PeriodicalId":18573,"journal":{"name":"MicrobiologyOpen","volume":"14 6","pages":""},"PeriodicalIF":4.6,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mbo3.70174","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}